IC
FATE icon

IEQ Capital’s Fate Therapeutics FATE Stock Holding History

IEQ Capital’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$390K Buy
324,788
+203,287
+167% +$248K ﹤0.01% 1412
2025
Q4 		$119K Sell
121,501
-16,060
-12% -$19.3K ﹤0.01% 1749
2025
Q3 		$173K Buy
137,561
+20,504
+18% +$22.1K ﹤0.01% 1701
2025
Q2 		$131K Buy
117,057
+42,551
+57% +$49.5K ﹤0.01% 1685
2025
Q1 		$58.9K Buy
+74,506
New +$91.3K ﹤0.01% 1538

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IEQ Capital's FATE Position: Q1 2026 in Review

IEQ Capital increased its Fate Therapeutics (FATE) stake by 167% in Q1 2026, buying an estimated $248K and bringing the position to 324,788 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

IEQ Capital first reported a position in FATE in Q1 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold FATE as of Q1 2026.

  • IEQ Capital held 324,788 shares of Fate Therapeutics worth $390K as of Q1 2026.
  • IEQ Capital bought 203,287 Fate Therapeutics shares in Q1 2026, an estimated $248K.
  • Fate Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1412 holding.
  • IEQ Capital first reported a position in Fate Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.